Davide Serrano
Overview
Explore the profile of Davide Serrano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manna E, Serrano D, Cazzaniga L, Mannucci S, Zanzottera C, Fava F, et al.
Genes (Basel)
. 2025 Jan;
16(1).
PMID: 39858629
Women carrying pathogenic/likely pathogenic (P/LP) variants in moderate- or high-penetrance genes have an increased risk of developing breast cancer. However, most P/LP variants associated with breast cancer risk show incomplete...
2.
Cazzaniga L, Zanzottera C, Mannucci S, Fava F, Marabelli M, Calvello M, et al.
Tumori
. 2025 Jan;
3008916241312530.
PMID: 39831439
Lynch syndrome is a genetic condition predisposing to cancer, particularly colorectal cancer and endometrial cancer, due to germline mutations in MisMatch Repair genes. More rarely, Lynch syndrome is the result...
3.
Guerrieri-Gonzaga A, Serrano D, Gnagnarella P, Johansson H, Zovato S, Nardi M, et al.
PLoS One
. 2024 Sep;
19(9):e0309511.
PMID: 39226292
Background: Breast Cancer (BC) prevention strategies range from lifestyle changes such as increasing physical activity and reducing body weight to preventive drugs like tamoxifen, known to reduce BC incidence in...
4.
Serrano D, Johansson H, Bertelsen B, Gandini S, Mellgren G, Thomas P, et al.
J Natl Cancer Inst
. 2024 Aug;
116(12):1979-1982.
PMID: 39110531
The drug's activity at the target tissue could help to define the minimal effective dose to promote cancer preventive therapy. Here we present exemestane and sex hormone concentrations within breast...
5.
Ruscica M, Macchi C, Gandini S, Macis D, Guerrieri-Gonzaga A, Aristarco V, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611089
Background And Aim: The involvement of cholesterol in cancer development remains a topic of debate, and its association with breast cancer has yet to be consistently demonstrated. Considering that circulating...
6.
Aristarco V, Serrano D, Maisonneuve P, Guerrieri-Gonzaga A, Lazzeroni M, Feroce I, et al.
Cancer Prev Res (Phila)
. 2024 Mar;
17(6):255-263.
PMID: 38530139
Prevention Relevance: Fenretinide exhibits beneficial effects on the metabolic profile, supporting its clinical use in breast cancer prevention especially in premenopausal women with a positive family history and pathogenic variants...
7.
Johansson H, Guerrieri-Gonzaga A, Gandini S, Bertelsen B, Macis D, Serrano D, et al.
NPJ Breast Cancer
. 2024 Jan;
10(1):7.
PMID: 38238336
In a 3-arm presurgical trial, four-six weeks exemestane 25 mg three times/week (TIW) was non-inferior to 25 mg/day (QD) in suppressing circulating estradiol in postmenopausal women with ER-positive breast cancer....
8.
Marabelli M, Bertario L, Serrano D
Genes (Basel)
. 2023 Sep;
14(9).
PMID: 37761961
According to the latest estimate from GLOBOCAN 2020, approximately 18 [...].
9.
Manna E, Serrano D, Aurilio G, Bonanni B, Lazzeroni M
Healthcare (Basel)
. 2023 Aug;
11(16).
PMID: 37628558
Female breast cancer is the most commonly diagnosed malignancy worldwide. Risk assessment helps to identify women at increased risk of breast cancer and allows the adoption of a comprehensive approach...
10.
Serrano D, Bellerba F, Johansson H, Macis D, Aristarco V, Accornero C, et al.
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371861
Vitamin D and a healthy diet, based on World Cancer Research Fund (WCRF) recommendations, are considered key elements for colorectal cancer (CRC) prevention. In a CRC case-control study, we observed...